Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
New fellows of the academy of medical sciences
From left Anke Ehlers, Gary Ford and John Stein

Anke Ehlers from the Oxford Centre for Anxiety Disorders and Trauma was recognized for her pioneering research into post-traumatic stress disorder. The success of her research has been acknowledged worldwide and has led to the development of an effective therapy for PTSD that has been approved by the NICE as one of the first line treatments for post-traumatic stress disorder. This features among our key neuroscience research impacts

Gary Ford, CEO of the Oxford Academic Health Science Network was recognized for over 20 years of innovation in stroke care. This period has seen substantial changes in the approach to stroke research. As a result, there have been huge changes in the early treatment of stroke patients and acute stroke care.  He remains a practising clinician as a Consultant Stroke Physician at Oxford University Hospitals NHS Trust and was awarded the CBE in 2013 for services to research in stroke medicine.

Emeritus Professor, John Stein from DPAG was recognized for his research into how vision controls movement in animals, patients with movement disorders, dyslexic children and antisocial offenders.  Through collaboration with neurosurgeon, Tipu Aziz, he has contributed to the use of deep brain stimulation to prevent spontaneous oscillations in both Parkinson’s disease and neuropathic pain. Other collaborations have led to the use of yellow or blue filters to improve reading and omega-3 supplements to improve attention, social interactions, behaviour and reading progress in young people and offenders.